Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

380 ARTÍCULOS , VIENDO DEL 226 AL 240

Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer's disease

Wenzel TJ, Klegeris A.

Life Sci. 2018 Aug 15;207:314-322. doi: 10.1016/j.lfs.2018.06.025. Epub 2018 Jun 22.

Nutritional Intervention to Prevent Alzheimer's Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined

Nolan JM, Mulcahy R, Power R, Moran R, Howard AN.

J Alzheimers Dis. 2018;64(2):367-378. doi: 10.3233/JAD-180160.

Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function

Zhu K, Peters F, Filser S, Herms J.

Biol Psychiatry. 2018 Oct 1;84(7):478-487. doi: 10.1016/j.biopsych.2018.04.022. Epub 2018 Jun 23.

Dendritic Cells as an Alternate Approach for Treatment of Neurodegenerative Disorders

Brezovakova V, Valachova B, Hanes J, Novak M, Jadhav S.

Cell Mol Neurobiol. 2018 Aug;38(6):1207-1214. doi: 10.1007/s10571-018-0598-1. Epub 2018 Jun 13.

Therapeutic Advancement in Alzheimer Disease: New Hopes on the Horizon?

Singh A, Hasan A, Tiwari S, Pandey LM.

CNS Neurol Disord Drug Targets. 2018;17(8):571-589. doi: 10.2174/1871527317666180627122448.

Apolipoprotein E Gene Polymorphisms Affect the Efficacy of Thiazolidinediones for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Iketani R, Ohno K, Kawasaki Y, Matsumoto K, Yamada H, Kishino S.

Biol Pharm Bull. 2018;41(7):1017-1023. doi: 10.1248/bpb.b17-00929.

Comparison of the effects of selenomethionine and selenium-enriched yeast in the triple-transgenic mouse model of Alzheimer's disease

Zhang ZH , Wu QY , Chen C , Zheng R , Chen Y , Ni JZ , Song GL .

Food Funct. 2018 Jul 17;9(7):3965-3973. doi: 10.1039/c7fo02063e.

Protective roles of melatonin against the amyloid-dependent development of Alzheimer's disease: A critical review

Vincent B.

Pharmacol Res. 2018 Aug;134:223-237. doi: 10.1016/j.phrs.2018.06.011. Epub 2018 Jul 5.

A Review on the Relationship between Tocotrienol and Alzheimer Disease

Chin KY, Tay SS.

Nutrients. 2018 Jul 9;10(7):881. doi: 10.3390/nu10070881.

A molecular approach in drug development for Alzheimer's disease

Agatonovic-Kustrin S, Kettle C, Morton DW.

Biomed Pharmacother. 2018 Oct;106:553-565. doi: 10.1016/j.biopha.2018.06.147. Epub 2018 Jul 11.

Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study

Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, Ossinalde C, Silverman DH.

Exp Gerontol. 2018 Oct 1;111:118-121. doi: 10.1016/j.exger.2018.07.009. Epub 2018 Jul 10.

Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease

Devanand DP.

Curr Neurol Neurosci Rep. 2018 Jul 14;18(9):55. doi: 10.1007/s11910-018-0863-1.

Liraglutide for psychiatric disorders: clinical evidence and challenges

Camkurt MA, Lavagnino L, Zhang XY, Teixeira AL.

Horm Mol Biol Clin Investig. 2018 Jul 18;36(2):/j/hmbci.2018.36.issue-2/hmbci-2018-0031/hmbci-2018-0031.xml. doi: 10.1515/hmbci-2018-0031.

Exploring the potential of marine microbes in clinical management of Alzheimer's disease: A road map for bioprospecting and identifying promising isolates

Muralidharan A, Josyula VR, Hariharapura RC.

Life Sci. 2018 Sep 1;208:149-160. doi: 10.1016/j.lfs.2018.07.036. Epub 2018 Jul 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias